Literature DB >> 10146931

Improving the quality and cost-effectiveness of prescribing.

J Avorn1.   

Abstract

The 1980s witnessed the evolution of a number of programmes designed to improve the quality and economy of medication use. In the approach known as 'academic detailing', the effective communications techniques of the pharmaceutical industry are employed in the service of programmes designed to promote rational medication use, rather than to maximise sales of a particular product. Using this method, a balanced, concise presentation of the best available current research and cost literature is put into an engaging, readable format, and presented to the physician in a one-on-one interactive educational session by a pharmacist. In randomised controlled trials in 5 states, this approach has been shown to be effective in reducing inappropriate prescribing; benefit-cost analyses have shown that it generates savings that exceed programme costs. On the other hand, the 1980s also saw the implementation of several alternative approaches to changing prescribing practice, often through crude bureaucratic measures uninformed by the realities of clinical practice. Many such policies have proven to be either ineffective or counterproductive clinically and/or economically. As the issue of drug utilisation review receives increasing attention in the 1990s, it will be important to assimilate the lessons of the last 10 years to design programmes in both the public and private sectors that will enhance the quality of drug therapy while containing its costs.

Mesh:

Year:  1992        PMID: 10146931     DOI: 10.2165/00019053-199200011-00011

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  4 in total

1.  Economic and policy analysis of university-based drug "detailing".

Authors:  S B Soumerai; J Avorn
Journal:  Med Care       Date:  1986-04       Impact factor: 2.983

2.  Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing".

Authors:  J Avorn; S B Soumerai
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

3.  Scientific versus commercial sources of influence on the prescribing behavior of physicians.

Authors:  J Avorn; M Chen; R Hartley
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

4.  Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

Authors:  S B Soumerai; J Avorn; D Ross-Degnan; S Gortmaker
Journal:  N Engl J Med       Date:  1987-08-27       Impact factor: 91.245

  4 in total
  4 in total

1.  Therapeutic substitution: an option for cost-effective prescribing?

Authors:  S R Shulman; W Gouveia
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981

2.  Physician education and prescribing costs.

Authors:  H J Vosper; T C Frewen
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

3.  Therapeutic dilemmas. An approach to the management of expensive pharmaceutical advances.

Authors:  L Y Nishimura; R Shane
Journal:  Pharmacoeconomics       Date:  1994-12       Impact factor: 4.981

4.  Key Features of Academic Detailing: Development of an Expert Consensus Using the Delphi Method.

Authors:  James S Yeh; Thomas J Van Hoof; Michael A Fischer
Journal:  Am Health Drug Benefits       Date:  2016-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.